Cargando…
Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series
Among the three grades of neuroendocrine tumors (NETs), the prognosis for Grade 1 (G1) with surgery is very good. Therefore, we evaluated the prognoses of pancreatic NET (PNET) G1 patients without surgery. A total of 8 patients who were diagnosed with NET G1, with an observation period of more than...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465021/ https://www.ncbi.nlm.nih.gov/pubmed/28638801 http://dx.doi.org/10.5306/wjco.v8.i3.293 |
_version_ | 1783242874552320000 |
---|---|
author | Sugimoto, Mitsuru Takagi, Tadayuki Suzuki, Rei Konno, Naoki Asama, Hiroyuki Watanabe, Ko Nakamura, Jun Kikuchi, Hitomi Waragai, Yuichi Takasumi, Mika Kawana, Satoshi Hashimoto, Yuko Hikichi, Takuto Ohira, Hiromasa |
author_facet | Sugimoto, Mitsuru Takagi, Tadayuki Suzuki, Rei Konno, Naoki Asama, Hiroyuki Watanabe, Ko Nakamura, Jun Kikuchi, Hitomi Waragai, Yuichi Takasumi, Mika Kawana, Satoshi Hashimoto, Yuko Hikichi, Takuto Ohira, Hiromasa |
author_sort | Sugimoto, Mitsuru |
collection | PubMed |
description | Among the three grades of neuroendocrine tumors (NETs), the prognosis for Grade 1 (G1) with surgery is very good. Therefore, we evaluated the prognoses of pancreatic NET (PNET) G1 patients without surgery. A total of 8 patients who were diagnosed with NET G1, with an observation period of more than 6 mo until surgery or without surgery, were recruited. The patients who underwent surgery were ultimately diagnosed using specimens obtained during the surgery, whereas the patients who did not undergo surgery were diagnosed using specimens obtained by endoscopic ultrasonography-guided fine needle aspiration. Overall, we mainly evaluated the observation period and tumor growth. The observation period for the five cases with surgery ranged from 6-80 mo, and tumor growth was observed in one case. In contrast, the observation period for the three cases without surgery ranged from 17-54 mo, and tumor growth was not observed. Therefore, although the first-choice treatment for NETs is surgery, our experience includes certain NET G1 patients who were followed up without surgery. |
format | Online Article Text |
id | pubmed-5465021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-54650212017-06-22 Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series Sugimoto, Mitsuru Takagi, Tadayuki Suzuki, Rei Konno, Naoki Asama, Hiroyuki Watanabe, Ko Nakamura, Jun Kikuchi, Hitomi Waragai, Yuichi Takasumi, Mika Kawana, Satoshi Hashimoto, Yuko Hikichi, Takuto Ohira, Hiromasa World J Clin Oncol Case Report Among the three grades of neuroendocrine tumors (NETs), the prognosis for Grade 1 (G1) with surgery is very good. Therefore, we evaluated the prognoses of pancreatic NET (PNET) G1 patients without surgery. A total of 8 patients who were diagnosed with NET G1, with an observation period of more than 6 mo until surgery or without surgery, were recruited. The patients who underwent surgery were ultimately diagnosed using specimens obtained during the surgery, whereas the patients who did not undergo surgery were diagnosed using specimens obtained by endoscopic ultrasonography-guided fine needle aspiration. Overall, we mainly evaluated the observation period and tumor growth. The observation period for the five cases with surgery ranged from 6-80 mo, and tumor growth was observed in one case. In contrast, the observation period for the three cases without surgery ranged from 17-54 mo, and tumor growth was not observed. Therefore, although the first-choice treatment for NETs is surgery, our experience includes certain NET G1 patients who were followed up without surgery. Baishideng Publishing Group Inc 2017-06-10 2017-06-10 /pmc/articles/PMC5465021/ /pubmed/28638801 http://dx.doi.org/10.5306/wjco.v8.i3.293 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Case Report Sugimoto, Mitsuru Takagi, Tadayuki Suzuki, Rei Konno, Naoki Asama, Hiroyuki Watanabe, Ko Nakamura, Jun Kikuchi, Hitomi Waragai, Yuichi Takasumi, Mika Kawana, Satoshi Hashimoto, Yuko Hikichi, Takuto Ohira, Hiromasa Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series |
title | Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series |
title_full | Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series |
title_fullStr | Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series |
title_full_unstemmed | Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series |
title_short | Pancreatic neuroendocrine tumor Grade 1 patients followed up without surgery: Case series |
title_sort | pancreatic neuroendocrine tumor grade 1 patients followed up without surgery: case series |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465021/ https://www.ncbi.nlm.nih.gov/pubmed/28638801 http://dx.doi.org/10.5306/wjco.v8.i3.293 |
work_keys_str_mv | AT sugimotomitsuru pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT takagitadayuki pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT suzukirei pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT konnonaoki pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT asamahiroyuki pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT watanabeko pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT nakamurajun pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT kikuchihitomi pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT waragaiyuichi pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT takasumimika pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT kawanasatoshi pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT hashimotoyuko pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT hikichitakuto pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries AT ohirahiromasa pancreaticneuroendocrinetumorgrade1patientsfollowedupwithoutsurgerycaseseries |